Mercaptor, Inc.

Mercaptor is a privately held clinical-stage company with a proprietary drug design platform in the field of neurology. The company was founded in October 2016 by a team of scientists who discovered an injury-activated molecule with the potential to mitigate brain damage when used prophylactically and to treat many neurodegenerative diseases. The team took a leap of faith and became a self-seeded enterprise with a clear goal: adapting their discovery to treat debilitating conditions of the brain. Mercaptor is on a mission to beat brain injuries including TBI, CTE, Alzheimer’s, Parkinson’s and more. Check out Mercaptor’s site http://www.mercaptordiscoveries.com. Contribute to the cause at www.mercaptor.com, check out our videos at https://www.youtube.com/c/MercaptorDiscoveries, and like our Facebook page: https://www.facebook.com/MercaptorDiscoveries/